|
Market Closed -
OTC Markets
15:20:34 2026-06-04 EDT
|
5-day change | 1st Jan Change | ||
| 0.0143 USD | -4.67% |
|
+3,475.00% | -55.28% |
Company Valuation: Windtree Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 173.8 | 86.8 | 45.36 | 6.564 | 3.701 | 3.859 |
| Change | - | -50.07% | -47.74% | -85.53% | -43.61% | 4.27% |
| Enterprise Value (EV) 1 | 172.6 | 88.65 | 40.9 | 17.67 | 16.21 | 3.574 |
| Change | - | -48.63% | -53.86% | -56.8% | -8.26% | -77.95% |
| P/E | - | - | - | - | - | -0.17x |
| PBR | - | - | - | - | - | 0.45x |
| PEG | - | - | - | - | - | - |
| Capitalization / Revenue | 878x | - | - | - | - | - |
| EV / Revenue | 872x | - | - | - | - | - |
| EV / EBITDA | -6.99x | -3.03x | -1.28x | -0.83x | -0.97x | -0.15x |
| EV / EBIT | -6.93x | -3.01x | -1.27x | -0.82x | -0.96x | -0.15x |
| EV / FCF | -11.1x | -6.01x | -3.05x | -1.4x | -2.15x | -0.28x |
| FCF Yield | -8.99% | -16.6% | -32.8% | -71.4% | -46.5% | -360% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | - | - | - | - | - | -104.3 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 0.198 | - | - | - | - | - |
| EBITDA 1 | -24.7 | -29.25 | -32.07 | -21.36 | -16.76 | -24.44 |
| EBIT 1 | -24.89 | -29.42 | -32.26 | -21.49 | -16.84 | -24.52 |
| Net income 1 | -27.48 | -32.57 | -67.64 | -39.21 | -20.29 | -1.787 |
| Net Debt 1 | -1.265 | 1.851 | -4.455 | 11.11 | 12.51 | -0.285 |
| Reference price 2 | 573,750.573750 | 230,850.230850 | 72,225.072225 | 7,650.007650 | 647.099482 | 17.465000 |
| Nbr of stocks (in thousands) | 0.3 | 0.38 | 0.63 | 0.86 | 5.72 | 221 |
| Announcement Date | 4/3/20 | 3/29/21 | 3/31/22 | 3/31/23 | 4/16/24 | 4/15/25 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 26.99K | |
| 16.87x | 6.34x | 12.15x | 1.77% | 63.77B | |
| 30.14x | 8.25x | 27.02x | 0.04% | 56.37B | |
| 37.48x | 6.65x | 19.86x | 0.86% | 54.62B | |
| 34.85x | 3.31x | 14.29x | -.--% | 44.06B | |
| 48.85x | 5.63x | 30.81x | -.--% | 42.11B | |
| -19.86x | 192.36x | -21.16x | -.--% | 41B | |
| 47.33x | 8.41x | 28.18x | -.--% | 34.92B | |
| 32x | 8.13x | 21.15x | 0.41% | 32.82B | |
| -70.14x | 13.02x | -68.47x | -.--% | 24.7B | |
| Average | 17.50x | 28.01x | 7.09x | 0.34% | 39.43B | |
| Weighted average by Cap. | 21.73x | 26.34x | 11.23x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- WINT Stock
- Valuation Windtree Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
